Munity+
Munity+, licence 80061834: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Fish Oil
- Licence holder
- Munity+ Canada Inc.
- NPN or DIN-HM
- 80061834
- Status
- Active licence
- Licence date
- 12 June 2015
- Revision date
- Not provided
- Form
- Capsule, enrobage gélatine
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Huile de poisson Source : Poisson d'huile de poisson - en entier Potency : 180.0 mg Eicosapentaenoic acid | 1000.0 milligramme | Not calculated |
| Huile de poisson Source : Poisson d'huile de poisson - en entier Potency : 120.0 mg Docosahexaenoic acid | Not specified | Not calculated |
Non-medicinal ingredients
Gélatine, d-alpha tocophérol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adolescents | minimum: 14.0 Année(s) ; maximum: 18.0 Année(s) | 1.0 Capsule | minimum: 1.0 Tous les jours ; maximum: 2.0 Tous les jours |
| Adolescentes | minimum: 9.0 Année(s) ; maximum: 13.0 Année(s) | 1.0 Capsule | minimum: 1.0 Tous les jours ; maximum: 2.0 Tous les jours |
| Adultes | Not specified | 1.0 Capsule | minimum: 1.0 Tous les jours ; maximum: 3.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps support cognitive health and brain function. Helps support the development of the brain, eyes and nerves in children up to 12 years of age. Helps reduce triglycerides levels and maintain cardiovascular health. Helps to reduce the pain of rheumatoid arthritis in adults when used in conjunction with conventional therapy.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80061834
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.